Gossamer Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Gossamer Bio, Inc. (GOSS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-56.53-179.82-229.38-234.00-243.36-180.31-146.97
Depreciation & Amortization4.154.394.435.174.270.960.30
Stock Based Compensation20.6228.5242.5532.0138.750.000.00
Change in Working Capital39.46-14.84-4.460.77-3.10-1.5615.02
Change in Accounts Receivable-5.340.000.000.000.000.000.00
Change in Accounts Payable-1.663.99-1.81-4.436.980.000.00
Change in Other Working Capital-9.47-18.83-2.655.20-10.080.000.00
Other Operating Activities1.0918.2439.326.8150.4530.9249.66
Net Cash from Operating Activities-3.47-159.16-187.03-188.89-176.36-144.83-51.04
Investing Activities
Capital Expenditures0.000.00-0.41-1.55-1.502.97-3.49
Purchases of Investments29.02-110.97-0.56-115.81240.230.000.00
Sales/Maturities of Investments523.80330.70-0.07-0.08-23.38-144.18-123.50
Other Investing Activities0.000.00237.4436.15325.81354.900.00
Net Cash from Investing Activities29.02-110.97-1.04-117.43215.34-147.14-144.71
Financing Activities
Debt Repayment-12.58-11.61-5.810.000.000.00-0.04
Common Stock Issued0.63201.77122.903.33118.94291.31303.04
Common Stock Repurchased0.630.000.000.000.000.000.00
Other Financing Activities0.460.000.000.000.000.00-2.14
Net Cash from Financing Activities-11.49190.15117.093.33312.54321.58300.86
Summary
Effect of Forex Changes on Cash-0.100.11-0.52-0.170.010.070.00
Net Change in Cash13.97-79.86-71.49-303.15351.5329.67105.10
Cash at Beginning of Period32.11111.97183.47486.62135.09105.420.32
Cash at End of Period46.07-159.16111.97183.47486.62135.09105.42
Free Cash Flow-3.47-159.16-187.44-190.44-177.86-147.80-72.26
Supplemental Disclosures
Interest Paid10.5612.2912.7112.747.871.480.12